Celularity, Inc. CELU
1.38
0.06
4.55%
as of 25 Sep
- Market cap
- $38.2M
- P/E
- 0.0×
Follow CELU
| Dec '25 | Sep '25 | Jun '25 | Mar '25 | Older periods | |
|---|---|---|---|---|---|
| 628.23% | 5,731.84% | (6,367.24%) | (432.29%) |
+8 more TTM periods Free account |
|
| (76.50%) | (66.35%) | (57.60%) | (40.80%) | ||
ROIC |
(1,070.92%) | (153.64%) | (172.59%) | (69.40%) | |
Return on Tangible Assets |
726.09% | (3,218.16%) | (1,098.23%) | (236.49%) | |
Average Days of Receivables |
63.97 | 60.31 | 91.29 | 107.20 | |
Free Cash Flow per Share |
(0.52) | (0.25) | (0.11) | (0.21) | |
Free Cash Flow |
(13.25) | (6.56) | (2.54) | (4.99) | |
Piotroski F-Score |
1.00 | 1.00 | 3.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
(83.21%) | (32.81%) | (13.52%) | (13.16%) | |
Accounts Receivable Turnover |
2.92 | 5.24 | 3.62 | 3.31 | |
Accounts Payable Turnover |
0.81 | 1.00 | 1.05 | 0.93 | |
Inventory Turnover |
6.71 | 6.14 | 5.47 | 3.42 | |
Average Days of Payables |
480.42 | 447.75 | 444.81 | 503.42 | |
Days of Inventory on Hand |
10.38 | 46.67 | 80.39 | 133.82 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
56.59% | 38.21% | 33.24% | 29.96% | |
Selling, General and Administrative Expense of Revenue |
193.09% | 128.79% | 124.70% | 115.52% | |
Share Based Compensation of Revenue |
39.09% | 24.81% | 23.99% | 22.05% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.14 | 0.08 | 0.03 | 0.09 | |
Depreciation/Fixed assets |
0.13 | 0.13 | 0.13 | 0.13 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
1.04 | 1.54 | 1.86 | 2.17 | |
Operating CF per Share |
(0.52) | (0.25) | (0.11) | (0.21) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(345.76%) | (198.75%) | (165.21%) | (109.16%) |
Columns are period end dates